Issue of 9,50,000 Shares on Preferential basis

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹68.19

prior close

₹70.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+2.0% vs market

Industrial Gases peers, median of 5sector-0.7%+2.4% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.4 pts more than its Industrial Gases peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6-0.4+2.0-0.7+2.4

Next day

+2.7+1.1+1.6+0.9+1.7

+0.2+1.0-0.9-0.6+0.7

+3.6+2.6+1.0+3.4+0.1

+19.7+4.2+15.5+7.2+12.5

+13.0+4.2+8.9+4.2+8.8

+7.1-0.5+7.5+1.8+5.3

15d

+12.8+0.9+11.8+6.8+6.0

+7.1+1.5+5.6-1.1+8.1

-26.7+9.1-35.8-0.5-26.2

-20.0+8.1-28.1-3.6-16.5

UpDownMarket · Nifty Microcap 250Sector · Industrial Gases peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

National Oxygen Limited's board has approved issuing 9.5 lakh equity shares at Rs. 93.80 per share to Saraf Housing Development Private Limited, a promoter group company. The total fundraising amounts to Rs. 8.91 crore. The issue price is above the minimum price of Rs. 73.80 set by a registered valuer under SEBI ICDR Regulations. The company also increased its authorized share capital from Rs. 17.10 crore to Rs. 18.10 crore. Shareholder approval will be sought at an EGM scheduled for May 28, 2026.

Likely market impact

Promoter group stake will increase, diluting minority shareholders. The Rs. 8.91 crore infusion provides capital but the preferential allotment to insiders at a ~27% premium above valuation floor may raise governance concerns for retail investors.